92 related articles for article (PubMed ID: 19800312)
1. Fibroblast growth factor receptor 1 regulates the differentiation and activation of osteoclasts through Erk1/2 pathway.
Lu X; Su N; Yang J; Huang W; Li C; Zhao L; He Q; Du X; Shen Y; Chen B; Chen L
Biochem Biophys Res Commun; 2009 Dec; 390(3):494-9. PubMed ID: 19800312
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase.
Chikazu D; Hakeda Y; Ogata N; Nemoto K; Itabashi A; Takato T; Kumegawa M; Nakamura K; Kawaguchi H
J Biol Chem; 2000 Oct; 275(40):31444-50. PubMed ID: 10896947
[TBL] [Abstract][Full Text] [Related]
3. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Luchin A; Purdom G; Murphy K; Clark MY; Angel N; Cassady AI; Hume DA; Ostrowski MC
J Bone Miner Res; 2000 Mar; 15(3):451-60. PubMed ID: 10750559
[TBL] [Abstract][Full Text] [Related]
4. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
5. Erk1 positively regulates osteoclast differentiation and bone resorptive activity.
He Y; Staser K; Rhodes SD; Liu Y; Wu X; Park SJ; Yuan J; Yang X; Li X; Jiang L; Chen S; Yang FC
PLoS One; 2011; 6(9):e24780. PubMed ID: 21961044
[TBL] [Abstract][Full Text] [Related]
6. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
[TBL] [Abstract][Full Text] [Related]
8. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
[TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
[TBL] [Abstract][Full Text] [Related]
10. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
11. Titanium IV ions induced human osteoclast differentiation and enhanced bone resorption in vitro.
Cadosch D; Chan E; Gautschi OP; Meagher J; Zellweger R; Filgueira L
J Biomed Mater Res A; 2009 Oct; 91(1):29-36. PubMed ID: 18683234
[TBL] [Abstract][Full Text] [Related]
12. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
13. Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation.
Hattersley G; Chambers TJ
Endocrinology; 1989 Apr; 124(4):1689-96. PubMed ID: 2924719
[TBL] [Abstract][Full Text] [Related]
14. Oxidized low density lipoprotein decreases Rankl-induced differentiation of osteoclasts by inhibition of Rankl signaling.
Mazière C; Louvet L; Gomila C; Kamel S; Massy Z; Mazière JC
J Cell Physiol; 2009 Dec; 221(3):572-8. PubMed ID: 19725047
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of activated monocytes into osteoclast-like cells on a hydroxyapatite substrate: an in vitro study.
Narducci P; Nicolin V
Ann Anat; 2009 Oct; 191(4):349-55. PubMed ID: 19447592
[TBL] [Abstract][Full Text] [Related]
16. Tyro 3 receptor tyrosine kinase and its ligand, Gas6, stimulate the function of osteoclasts.
Nakamura YS; Hakeda Y; Takakura N; Kameda T; Hamaguchi I; Miyamoto T; Kakudo S; Nakano T; Kumegawa M; Suda T
Stem Cells; 1998; 16(3):229-38. PubMed ID: 9617898
[TBL] [Abstract][Full Text] [Related]
17. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
Wei P; Jiao L; Qin LP; Yan F; Han T; Zhang QY
Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):342-8. PubMed ID: 19361364
[TBL] [Abstract][Full Text] [Related]
18. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.
Jimi E; Akiyama S; Tsurukai T; Okahashi N; Kobayashi K; Udagawa N; Nishihara T; Takahashi N; Suda T
J Immunol; 1999 Jul; 163(1):434-42. PubMed ID: 10384146
[TBL] [Abstract][Full Text] [Related]
19. Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.
Zhen Y; Sørensen V; Jin Y; Suo Z; Wiedłocha A
Oncogene; 2007 Sep; 26(44):6372-85. PubMed ID: 17533378
[TBL] [Abstract][Full Text] [Related]
20. A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways.
Park JY; Bae MA; Cheon HG; Kim SS; Hong JM; Kim TH; Choi JY; Kim SH; Lim J; Choi CH; Shin HI; Kim SY; Park EK
Biochem Biophys Res Commun; 2009 Jan; 378(3):645-9. PubMed ID: 19059209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
